The leaders of the European Federation of Pharmaceutical Industries and Associations (EFPIA) have warned that the proposed reforms to the European Commission’s (EC) Pharmaceutical Legislation should be revised as they believe they risk damaging Europe’s capacity for innovation and international competitiveness.
The European Commission’s (EC) long-awaited proposals for reforming pharma legislation have been published. The main thrust of the proposals is to create a single EU market for medicines to replace existing fragmentation and improve access for EU citizens.
In our latest online breakfast briefing, PharmaMedic Consultancy’s Managing Director Malcolm Barratt-Johnson, welcomed Indira Walker of Iolite Pharma Consulting, to discuss the requirements for maintaining quality across the medicine development and manufacturing process, and the important role of the Qualified Person at every stage. Read on to discover the key points that should be considered to ensure success throughout the product life cycle – and how the QP is an integral part of that journey.
PMC reviews insights from the 41st JP Morgan Healthcare conference, focusing on some of the new treatments and technologies to watch out for in the pharma industry this year – and highlighting challenges to progress.
Medical affairs is an increasingly complex discipline. It is vital that the team is highly trained and able to adapt to an evolving environment, liaising effectively with stakeholders to communicate value and bring new treatments to the market. Read on to discover some of the challenges and trends affecting the sector.
